These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29285751)

  • 41. JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats.
    Wen S; Wang C; Huo X; Meng Q; Liu Z; Yang S; Zhu Y; Sun H; Ma X; Liu K
    Toxicol Lett; 2018 Oct; 295():195-204. PubMed ID: 29964132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters.
    Wong CC; Barron D; Orfila C; Dionisi F; Krajcsi P; Williamson G
    Mol Nutr Food Res; 2011 Jul; 55(7):979-88. PubMed ID: 21538853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ontogeny of expression of organic anion transporters 1 and 3 in ovine fetal and neonatal kidney.
    Wood CE; Cousins R; Zhang D; Keller-Wood M
    Exp Biol Med (Maywood); 2005 Oct; 230(9):668-73. PubMed ID: 16179735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous metabolites that are substrates of organic anion transporter's (OATs) predict methotrexate clearance.
    Muhrez K; Benz-de Bretagne I; Nadal-Desbarats L; Blasco H; Gyan E; Choquet S; Montigny F; Emond P; Barin-Le Guellec C
    Pharmacol Res; 2017 Apr; 118():121-132. PubMed ID: 27210722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions of human organic anion as well as cation transporters with indoxyl sulfate.
    Enomoto A; Takeda M; Taki K; Takayama F; Noshiro R; Niwa T; Endou H
    Eur J Pharmacol; 2003 Apr; 466(1-2):13-20. PubMed ID: 12679137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions.
    Jamshidi N; Nigam SK
    Sci Rep; 2022 Oct; 12(1):18308. PubMed ID: 36316339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.
    Niemi M; Pasanen MK; Neuvonen PJ
    Pharmacol Rev; 2011 Mar; 63(1):157-81. PubMed ID: 21245207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequency of functional exonic single-nucleotide polymorphisms and haplotype distribution in the SLCO1B1 gene across genetic ancestry groups in the Qatari population.
    Dashti M; Al-Matrouk A; Channanath A; Al-Mulla F; Thanaraj TA
    Sci Rep; 2022 Sep; 12(1):14858. PubMed ID: 36050458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing.
    Rohrbacher M; Kirchhof A; Skarke C; Geisslinger G; Lötsch J
    Pharmacogenomics; 2006 Mar; 7(2):167-76. PubMed ID: 16515396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal expression of organic anion transporters is modified after mercuric chloride exposure: Gender-related differences.
    Hazelhoff MH; Bulacio RP; Chevalier A; Torres AM
    Toxicol Lett; 2018 Oct; 295():390-396. PubMed ID: 30031051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
    Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
    Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of
    Parvez MM; Shin HJ; Jung JA; Shin JG
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
    Kindla J; Müller F; Mieth M; Fromm MF; König J
    Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure.
    Vandell AG; Lee J; Shi M; Rubets I; Brown KS; Walker JR
    Pharmacogenomics J; 2018 Jan; 18(1):153-159. PubMed ID: 27897269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human organic anion transporter 2 is distinct from organic anion transporters 1 and 3 with respect to transport function.
    Henjakovic M; Hagos Y; Krick W; Burckhardt G; Burckhardt BC
    Am J Physiol Renal Physiol; 2015 Nov; 309(10):F843-51. PubMed ID: 26377792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Smilax glabra Rhizoma affects the pharmacokinetics and tissue distribution of methotrexate by increasing the P‑glycoprotein mRNA expression in rats after oral administration.
    Li Y; Deng S; Ζhao Y; Liu L; Zhao R
    Mol Med Rep; 2017 Nov; 16(5):7633-7640. PubMed ID: 28944899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delayed Methotrexate Elimination after Administration of a Medium Dose of Methotrexate in a Patient with Genetic Variants Associated with Methotrexate Clearance.
    Tatebe Y; Kanamitsu K; Kanzaki H; Ishida H; Fujiwara K; Washio K; Kitamura Y; Sendo T; Shimada A; Tsukahara H
    Acta Med Okayama; 2020 Dec; 74(6):545-550. PubMed ID: 33361876
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3.
    Ye J; Liu Q; Wang C; Meng Q; Peng J; Sun H; Kaku T; Liu K
    Eur J Pharm Sci; 2012 Sep; 47(2):341-6. PubMed ID: 22728397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters.
    Caetano-Pinto P; Jamalpoor A; Ham J; Goumenou A; Mommersteeg M; Pijnenburg D; Ruijtenbeek R; Sanchez-Romero N; van Zelst B; Heil SG; Jansen J; Wilmer MJ; van Herpen CML; Masereeuw R
    Mol Pharm; 2017 Jun; 14(6):2147-2157. PubMed ID: 28493713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.